For research use only. Not for therapeutic Use.
PKR activator 4 (example 7A) is a potent pyruvate kinase R (PKR) activator. PKR activator 4 has the potential for the research of blood disorders[1].
Catalog Number | I041289 |
CAS Number | 2283420-05-1 |
Synonyms | 7-methyl-4-[[1-(2-trimethylsilylethoxymethyl)pyrazol-3-yl]methyl]-3-thia-5,7,10,11-tetrazatricyclo[6.4.0.02,6]dodeca-1(8),2(6),4,11-tetraen-9-one |
Molecular Formula | C18H24N6O2SSi |
Purity | ≥95% |
InChI | InChI=1S/C18H24N6O2SSi/c1-23-15-13(10-19-21-18(15)25)16-17(23)20-14(27-16)9-12-5-6-24(22-12)11-26-7-8-28(2,3)4/h5-6,10H,7-9,11H2,1-4H3,(H,21,25) |
InChIKey | OJINPWVFOQGLEV-UHFFFAOYSA-N |
SMILES | CN1C2=C(C=NNC2=O)C3=C1N=C(S3)CC4=NN(C=C4)COCC[Si](C)(C)C |
Reference | [1]. Giovanni Cianchetta et al. Pyruvate kinase activators for use in treating blood disorders. WO2019035864A1. |